Union leads worker blockade of Sanofi plant

The General Confederation of Labour unions (CGT) in France led a Sanofi employee blockade of the drug giant's Romainville manufacturing plant earlier this week. The plant is used in API and drug production for antibiotics and corticosteroids.

The blockade protested plans announced for the plant's closure. The union said that the company's offer of reassignment to 80 of the plant's 170 employees was inadequate. Union officials said that Sanofi management had refused to consider proposals to continue operations at the site.

Sanofi announced early this month a restructuring expected to eliminate 25 percent of the work force in its 6,900-employee U.S. Pharmaceutical Operations, about 1,700 positions. Its intent is to shift resources to strategic treatment priorities, improve efficiency and simplify infrastructure.

- see the news from Boursier.com (translated by Google)
- see the Sanofi U.S. announcement

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.